Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$114.53
-5.3%
$117.11
$5.59
$148.83
$9.08B0.841.09 million shs941,219 shs
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$3.41
-13.4%
$2.74
$0.72
$5.05
$2.38B1.581.03 million shs1.11 million shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$19.85
-8.3%
$23.40
$12.40
$27.72
$9.92B1.695.26 million shs7.85 million shs
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$13.61
+0.9%
$13.59
$12.19
$16.17
$11.36B0.272.33 million shs2.27 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-0.75%-2.93%-3.82%-3.19%+1,883.61%
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.00%+0.41%+62.88%+62.81%+346.71%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-0.87%-10.06%-10.26%-13.95%+68.05%
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
+4.20%+0.48%+2.82%-4.23%-4.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$114.53
-5.3%
$117.11
$5.59
$148.83
$9.08B0.841.09 million shs941,219 shs
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$3.41
-13.4%
$2.74
$0.72
$5.05
$2.38B1.581.03 million shs1.11 million shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$19.85
-8.3%
$23.40
$12.40
$27.72
$9.92B1.695.26 million shs7.85 million shs
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$13.61
+0.9%
$13.59
$12.19
$16.17
$11.36B0.272.33 million shs2.27 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-0.75%-2.93%-3.82%-3.19%+1,883.61%
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.00%+0.41%+62.88%+62.81%+346.71%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-0.87%-10.06%-10.26%-13.95%+68.05%
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
+4.20%+0.48%+2.82%-4.23%-4.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
2.93
Moderate Buy$137.1519.75% Upside
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
3.75
Strong BuyN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.77
Moderate Buy$28.2042.04% Upside
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
2.00
Hold$16.9024.22% Upside

Current Analyst Ratings Breakdown

Latest CURLF, ELAN, RDY, and ABVX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
DowngradeHold (C+)Hold (C)
5/11/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
DowngradeSell (D+)Sell (D)
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetBuy$30.00 ➝ $31.00
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetOverweight$28.00 ➝ $30.00
5/5/2026
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
UpgradeHoldStrong-Buy
4/27/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UpgradeSell (D)Sell (D+)
4/27/2026
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
UpgradeHold (C)Hold (C+)
4/23/2026
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
DowngradeNeutralSell
4/20/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Reiterated RatingSell (D-)
4/15/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Initiated CoverageBuy$30.00
4/9/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Reiterated RatingOutperform
(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/AN/AN/AN/A$6.57 per shareN/A
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
$1.27B1.88$0.05 per share71.89$1.18 per share2.89
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.72B2.10$2.11 per share9.39$13.01 per share1.53
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$3.58B3.17$1.08 per share12.58$4.73 per share2.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-$380.27M-$5.37N/AN/AN/AN/A-146.43%-88.69%5/25/2026 (Estimated)
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$231.07M-$0.13N/AN/AN/A-7.76%-8.11%-2.36%N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$232M-$0.50N/A16.412.33-4.95%7.42%3.66%N/A
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$663M$0.7723.4621.941.8012.90%12.28%8.25%7/22/2026 (Estimated)

Latest CURLF, ELAN, RDY, and ABVX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/25/2026Q1 2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-$0.9359N/AN/AN/A$0.40 millionN/A
5/12/2026Q4 25/26
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$0.09$0.06-$0.03-$0.03$886.58 million$852.55 million
5/6/2026Q1 2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.34$0.40+$0.06$0.11$1.28 billion$1.37 billion
5/5/2026Q1 2026
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$0.08$0.09+$0.17$0.09$316.62 million$324.23 million
3/23/2026Q4 2025
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-$2.24-$1.20+$1.04-$1.20$1.80 million$0.52 million
2/26/2026Q4 2025
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
-$0.08-$0.05+$0.03-$0.08$328.70 million$333.07 million
2/24/2026Q4 2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.11$0.13+$0.02-$0.56$1.09 billion$1.14 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/AN/AN/AN/AN/A
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
N/AN/AN/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
$0.070.51%+9.86%9.09%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/A
8.75
8.75
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
1.05
1.56
0.74
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.60
2.16
1.12
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
0.03
1.88
1.38

Institutional Ownership

CompanyInstitutional Ownership
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
47.91%
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
0.03%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
3.85%

Insider Ownership

CompanyInsider Ownership
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/A
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
1.14%
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
2.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
6179.29 millionN/ANot Optionable
Curaleaf Holdings, Inc. stock logo
CURLF
Curaleaf
5,554698.20 millionN/ANot Optionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,400499.45 million493.76 millionOptionable
Dr. Reddy's Laboratories Ltd stock logo
RDY
Dr. Reddy's Laboratories
27,811834.65 million817.96 millionOptionable

Recent News About These Companies

Dr. Reddy's Laboratories Q4 Earnings Call Highlights
Doctor Reddy’s: Fiscal Q4 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abivax stock logo

Abivax NASDAQ:ABVX

$114.53 -6.47 (-5.35%)
Closing price 04:00 PM Eastern
Extended Trading
$114.79 +0.26 (+0.23%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Curaleaf stock logo

Curaleaf OTCMKTS:CURLF

$3.41 -0.53 (-13.35%)
As of 03:59 PM Eastern

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$19.85 -1.79 (-8.25%)
Closing price 03:59 PM Eastern
Extended Trading
$20.10 +0.25 (+1.24%)
As of 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Dr. Reddy's Laboratories stock logo

Dr. Reddy's Laboratories NYSE:RDY

$13.60 +0.12 (+0.85%)
Closing price 03:59 PM Eastern
Extended Trading
$13.62 +0.01 (+0.07%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.